Infarction D007238

Description

Formation of an infarct, which is NECROSIS in tissue due to local ISCHEMIA resulting from obstruction of BLOOD CIRCULATION, most commonly by a THROMBUS or EMBOLUS.   MeSH

Hierarchy View

Subtype Terms (5)

Brain Infarction
177 drugs (81 approved, 96 experimental)

Hepatic Infarction
 

Myocardial Infarction
321 drugs (183 approved, 138 experimental)

Pulmonary Infarction
4 drugs (3 approved, 1 experimental)


Phase 4 Indicated Drugs (126)

Key: D007238 (104) Subtype (22)

Phase 3 Indicated Drugs (101)

Key: D007238 (79) Subtype (22)

Phase 2 Indicated Drugs (131)

Key: D007238 (83) Subtype (48)


Organization Involved with Phase 4 Indications (201)

Key: D007238 (178) Subtype (23)

Organization Involved with Phase 3 Indications (148)

Key: D007238 (116) Subtype (32)

Organization Involved with Phase 2 Indications (133)

Key: D007238 (86) Subtype (47)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.